Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements

被引:113
作者
DiProspero, NA
Chen, EY
Charles, V
Plomann, M
Kordower, JH
Tagle, DA
机构
[1] Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA
[2] NHGRI, NIH, Bethesda, MD 20892 USA
[3] Rush Presbyterian Med Ctr, Chicago, IL 60612 USA
[4] Univ Cologne, Inst Biochem 2, D-50931 Cologne, Germany
[5] Univ Cologne, CMMC, D-50931 Cologne, Germany
来源
JOURNAL OF NEUROCYTOLOGY | 2004年 / 33卷 / 05期
关键词
D O I
10.1007/s11068-004-0514-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Huntingtons disease (HD) is caused by a polyglutamine repeat expansion in the N-terminus of the huntingtin protein. Huntingtin is normally present in the cytoplasm where it may interact with structural and synaptic elements. The mechanism of HD pathogenesis remains unknown but studies indicate a toxic gain-of-function possibly through aberrant protein interactions. To investigate whether early degenerative changes in HD involve alterations of cytoskeletal and vesicular components, we examined early cellular changes in the frontal cortex of HD presymptomatic (PS), early pathological grade (grade 1) and late-stage (grade 3 and 4) patients as compared to age-matched controls. Morphologic analysis using silver impregnation revealed a progressive decrease in neuronal fiber density and organization in pyramidal cell layers beginning in presymptomatic HD cases. Immunocytochemical analyses for the cytoskeletal markers alpha-tubulin, microtubule-associated protein 2, and phosphorylated neurofilament demonstrated a concomitant loss of staining in early grade cases. Immunoblotting for synaptic proteins revealed a reduction in complexin 2, which was marked in some grade 1 HD cases and significantly reduced in all late stage cases. Interestingly, we demonstrate that two synaptic proteins, dynamin and PACSIN 1, which were unchanged by immunoblotting, showed a striking loss by immunocytochemistry beginning in early stage HD tissue suggesting abnormal distribution of these proteins. We propose that mutant huntingtin affects proteins involved in synaptic function and cytoskeletal integrity before symptoms develop which may influence early disease onset and/or progression.
引用
收藏
页码:517 / 533
页数:17
相关论文
共 82 条
[1]  
AVILA J, 1994, INT J DEV BIOL, V38, P13
[2]   Frontal lobe volume in patients with Huntington's disease [J].
Aylward, EH ;
Anderson, NB ;
Bylsma, FW ;
Wagster, MV ;
Barta, PE ;
Sherr, M ;
Feeney, J ;
Davis, A ;
Rosenblatt, A ;
Pearlson, GD ;
Ross, CA .
NEUROLOGY, 1998, 50 (01) :252-258
[3]   REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID [J].
BEAL, MF ;
KOWALL, NW ;
ELLISON, DW ;
MAZUREK, MF ;
SWARTZ, KJ ;
MARTIN, JB .
NATURE, 1986, 321 (6066) :168-171
[4]   Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers [J].
Berrios, GE ;
Wagle, AC ;
Marková, IS ;
Wagle, SA ;
Ho, LW ;
Rubinsztein, DC ;
Whittaker, J ;
Ffrench-Constant, C ;
Kershaw, A ;
Rosser, A ;
Bak, T ;
Hodges, JR .
PSYCHIATRY RESEARCH, 2001, 102 (03) :217-225
[5]   Fast transport and retrograde movement of huntingtin and HAP 1 in axons [J].
BlockGalarza, J ;
Chase, KO ;
Sapp, E ;
Vaughn, KT ;
Vallee, RB ;
DiFiglia, M ;
Aronin, N .
NEUROREPORT, 1997, 8 (9-10) :2247-2251
[6]   Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia [J].
Bordelon, YM ;
Chesselett, MF .
NEUROSCIENCE, 1999, 93 (03) :843-853
[7]   PHOSPHORYLATION DETERMINES THE BINDING OF MICROTUBULE-ASSOCIATED PROTEIN-2 (MAP2) TO MICROTUBULES IN LIVING CELLS [J].
BRUGG, B ;
MATUS, A .
JOURNAL OF CELL BIOLOGY, 1991, 114 (04) :735-743
[8]  
Cepeda C, 2003, J NEUROSCI, V23, P961
[9]   Transcriptional dysregulation in Huntington's disease [J].
Cha, JHJ .
TRENDS IN NEUROSCIENCES, 2000, 23 (09) :387-392
[10]   DEGENERATION OF PYRAMIDAL PROJECTION NEURONS IN HUNTINGTONS-DISEASE CORTEX [J].
CUDKOWICZ, M ;
KOWALL, NW .
ANNALS OF NEUROLOGY, 1990, 27 (02) :200-204